Management tracks: Sanofi hires Atara's Berger; plus Emmaus, enGene and more

Two days after Atara Biotherapeutics Inc. (NASDAQ:ATRA) announced Dietmar Berger was departing as global head of R&D, Sanofi (Euronext:SAN; NASDAQ:SNY) has announced he will oversee its clinical portfolio as head of development. Prior to his year-long stint at the biotech, Berger held multiple roles at big biopharma companies, mostly recently at Genentech Inc., where he was SVP, global clinical development, hematology/oncology.

Emmaus Life Sciences Inc. (Torrance, Calif.) hired Jay Sherwood as CFO, effective June 3. He was a partner at G.C. Andersen Partners and replaces Kurt Kruger, who will remain with the sickle cell disease company as a consultant...